Evaluation of efficacy of heartworm preventive products at the FDA.
about
A research agenda for helminth diseases of humans: intervention for control and eliminationSelamectin for the prevention of canine Dirofilaria immitis infection: field efficacy in client-owned dogs in a high risk areaPolymorphism in ABC transporter genes of Dirofilaria immitis.Ivermectin and milbemycin oxime in experimental adult heartworm (Dirofilaria immitis) infection of dogs.How do the macrocyclic lactones kill filarial nematode larvae?Establishment of macrocyclic lactone resistant Dirofilaria immitis isolates in experimentally infected laboratory dogs.Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis.Mosquito-borne heartworm Dirofilaria immitis in dogs from Australia.Progress and challenges in the discovery of macrofilaricidal drugs.Increasing risks of human dirofilariasis in travelers.The emergence of macrocyclic lactone resistance in the canine heartworm, Dirofilaria immitis.Polymorphism in ion channel genes of Dirofilaria immitis: Relevant knowledge for future anthelmintic drug design.Dogs: The riddle of resistance.ABC-B transporter genes in Dirofilaria immitis.Development of an in vitro bioassay for measuring susceptibility to macrocyclic lactone anthelmintics in Dirofilaria immitisDoes evaluation of in vitro microfilarial motility reflect the resistance status of Dirofilaria immitis isolates to macrocyclic lactones?Effects of diagnostic test accuracy and treatment efficacy on the occurrence of suspected failure of heartworm prophylaxis in dogs.Investigating management choices for canine heartworm disease in northern Mississippi.Genetic profiles of ten Dirofilaria immitis isolates susceptible or resistant to macrocyclic lactone heartworm preventives.Increasing incidence of Dirofilaria immitis in dogs in USA with focus on the southeast region 2013-2016.Dirofilaria immitis JYD-34 isolate: whole genome analysis.Can P-glycoprotein and β-tubulin polymorphisms be used as genetic markers of resistance in Dirofilaria immitis from Rio de Janeiro, Brazil?Dirofilaria immitis Microfilariae and Third-Stage Larvae Induce Canine NETosis Resulting in Different Types of Neutrophil Extracellular Traps.
P2860
Q21562256-23D5071C-AA80-419A-AE1D-32AE4CD754D0Q26315247-55CB5826-F9F5-4C85-8BA8-2037AE1F2380Q33648348-F84CAB38-CBF2-46ED-94DC-E193A6A2591BQ33771117-9629322F-3F26-4FBA-B9AF-FA3F1A9F93A9Q33805501-477226FD-6FBB-42C5-917A-A903C6389F1FQ34492057-F8602A9E-238E-4BBA-AEEF-B7627DFF073CQ36765580-B861623F-BE16-4801-A172-1E5B65F558C0Q37322095-F65D42DD-3881-468C-A78E-51A20238E4CBQ37912232-78C4FA49-A62A-48FA-9677-802862AE788CQ38266618-BB2CB076-B6B9-4829-816B-C855A5139FBBQ38514816-1C016AB8-49D2-44DD-84B9-BA57FA29E34DQ38816689-327BC4E6-2359-4AB6-8953-DECEB320FDB8Q38869144-994B09D8-C996-40D2-9855-A4253A8F4FEEQ40680363-FF051DFD-3ABC-463A-B6D4-CF90EA35831DQ42228110-48593D6F-2E7D-413A-8189-880D3A9AF770Q44169932-585BDA0E-1078-4EF2-92AB-CF375F09D797Q44340839-6F936CA4-B0A6-413C-9E69-C23E0D785D50Q47147260-4F325F4E-AD3E-41E8-8B4B-FE29588A8B04Q47180114-44C52477-0A3B-4453-8ACC-F42162ABC2BDQ48224388-F263A269-C687-437D-9385-C320BC3F0930Q49972097-18DB065B-1129-43CF-A2B9-BA0FD1DA30AAQ52687923-A0A13460-2A6C-4A99-9AF3-27C34CA5C66FQ55361406-721C6924-25D8-462E-BF7A-27A1BAE68C77
P2860
Evaluation of efficacy of heartworm preventive products at the FDA.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Evaluation of efficacy of heartworm preventive products at the FDA.
@ast
Evaluation of efficacy of heartworm preventive products at the FDA.
@en
type
label
Evaluation of efficacy of heartworm preventive products at the FDA.
@ast
Evaluation of efficacy of heartworm preventive products at the FDA.
@en
prefLabel
Evaluation of efficacy of heartworm preventive products at the FDA.
@ast
Evaluation of efficacy of heartworm preventive products at the FDA.
@en
P1476
Evaluation of efficacy of heartworm preventive products at the FDA.
@en
P2093
Victoria A Hampshire
P304
P356
10.1016/J.VETPAR.2005.04.004
P577
2005-10-01T00:00:00Z